Involvement of amyloid β precursor protein (AβPP) modulated copper homeostasis in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 8, Issue 2, 2005, Pages 201-206

  Bayer, Thomas A ^a   Multhaup, Gerd ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Alzheimer's disease; Amyloid; A PP; Cu deficiency; Pathology; SOD 1; Transgenic model

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; BRAIN LEVEL; COPPER BLOOD LEVEL; COPPER DEFICIENCY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HOMEOSTASIS; HUMAN; ION TRANSPORT; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TISSUE DISTRIBUTION;

EID: 32444443485     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2005-8212     Document Type: Review

References (31)

1. T.A. Bayer, R. Cappai, C.L. Masters, K. Beyreuther and G. Multhaup, It all sticks together - the APP-related family of proteins and Alzheimer's disease, Mol Psychiatry 4 (1999), 524-528.
2. L. Hesse, D. Beher, C.L. Masters and G. Multhaup, The beta A4 amyloid precursor protein binding to copper, Febs Lett 349 (1994), 109-116.
3. C.S. Atwood, R.C. Scarpa, X. Huang, R.D. Moir, W.D. Jones, O.P. Fairlie, R.E. Tanzi and A.I. Bush, Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42, J Neurochem 75 (2000), 1219-1233.
4. G. Multhaup, A. Schlicksupp, L. Hesse, D. Beher, T. Ruppert, C.L. Masters and K. Beyreuther, The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I), Science 271 (1996), 1406-1409.
5. K.J. Barnham, W.J. McKinstry, G. Multhaup, D. Galatis, C.J. Morton, C.C. Curtain, N.A. Williamson, A.R. White, M.G. Hinds, R.S. Norton, K. Beyreuther, C.L. Masters, M.W. Parker and R. Cappai, Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis, J Biol Chem 278 (2003), 17401-17407.
6. A.I. Bush, The metallobiology of Alzheimer's disease, Trends Neurosci 26 (2003), 207-214.
7. G. Multhaup, S. Scheuermann, A. Schlicksupp, A. Simons, M. Strauss, A. Kemmling, C. Oehler, R. Cappai, R. Pipkorn and T.A. Bayer, Possible mechanisms of APP-mediated oxidative stress in Alzheimer's disease(1,2), Free Radic Biol Med 33 (2002), 45-51.
8. A.R. White, R. Reyes, J.F. Mercer, J. Camakaris, H. Zheng, A.I. Bush, G. Multhaup, K. Beyreuther, C.L. Masters and R. Cappai, Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice, Brain Res 842 (1999), 439-444.
9. C.J. Maynard, R. Cappai, I. Volitakis, R.A. Cherny, A.R. White, K. Beyreuther, C.L. Masters, A.I. Bush and Q.X. Li, Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron, J Biol Chem 277 (2002), 44670-14676.
10. T. Borchardt, J. Camakaris, R. Cappai, C.L. Masters, K. Beyreuther and G. Multhaup, Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion, Biochem J 344 (1999), 461-467.
11. A.L. Phinney, B. Drisaldi, S. Lugowski, S. Schmidt, H. Bonek, Y. Liang, P. Home, L. Yang, J. Sekoulidis, J. Coomaraswarmy, D. Cox, P.M. Mathews, R.A. Nixon, G.A. Carlson, P. St George-Hyslop and D. Westaway, In vivo reduction of amyloid Aβ by a mutant copper transporter, PNAS 100 (2003), 14193-14198.
12. T.A. Bayer, S. Schäfer, A. Simons, A. Kemmling, T. Kamer, R. Tepest, A. Eckert, K. Schüssel, O. Eikenberg, C. Sturchler-Pierrat, D. Abramowski, M. Staufenbiel and G. Multhaup, Dietary Cu stabilizes brain SOD-1 activity and reduces amyoid Aβ production in APP23 transgenic mice, PNAS 100 (2003), 14187-14192.
13. R.A. Cherny, C.S. Atwood, M.E. Xilinas, D.N. Gray, W.D. Jones, C.A. McLean, K.J. Barnham, I. Volitakis, F.W. Fraser, Y. Kim, X. Huang, L.E. Goldstein, R.D. Moir, J.T. Lim, K. Beyreuther, H. Zheng, R.E. Tanzi, C.L. Masters and A.I. Bush, Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits beta-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice, Neuron 30 (2001), 665-676.
14. C.L. Keen, P. Saltman and L.S. Hurley, Copper nitrilotriacetate: a potent therapeutic agent in the treatment of a genetic disorder of copper metabolism, Am J Clin Nutr 33 (1980), 1789-1800.
15. C. Treiber, A. Simons, M. Strauss, M. Hafner, R. Cappai, T.A. Bayer and G. Multhaup, Clioquinol Mediates Copper Uptake and Counteracts Copper Efflux Activities of the Amyloid Precursor Protein of Alzheimer's Disease, J. Biol. Chem. 279 (2004), 51958-51964.
16. D.L. Sparks and B.G. Schreurs, Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease, Proc Natl Acad Sci USA 100 (2003), 11065-11069.
17. A.I. Bush, C.L. Masters and R. Tanzi, Copper, β-amyloid, and Alzheimer's disease: tapping a sensitive connection, PNAS 100 (2003), 11193-11194.
18. R. Squitti, D. Lupoi, P. Pasqualetti, G. Dal Forno, F. Vernieri, P. Chiovenda, L. Rossi, M. Cortesi, E. Cassetta and P.M. Rossini, Elevation of serum copper levels in Alzheimer's disease, Neurology 59 (2002), 1153-1161.
19. C. Gonzalez, T. Martin, J. Cacho, M.T. Brenas, T. Arroyo, B. Garcia-Berrocal, J.A. Navajo and J.M. Gonzalez-Buitrago, Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers, Eur J Clin Invest 29 (1999), 637-642.
20. C. Jeandel, M.B. Nicolas, F. Dubois, F. Nabet-Belleville, F. Penin and G. Cuny, Lipid peroxidation and free radical scavengers in Alzheimer's disease, Gerontology 35 (1989), 275-282.
21. M.A. Deibel, W.D. Ehmann and W.R. Markesbery, Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress, J Neurol Sci 143 (1996), 137-142.
22. D.A. Loeffler, P.A. LeWitt, P.L. Juneau, A.A. Sima, H.U. Nguyen, A.J. DeMaggio, C.M. Brickman, G.J. Brewer, R.D. Dick, M.D. Troyer and L. Kanaley, Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders, Brain Res 738 (1996), 265-274.
23. J.R. Connor, P. Tucker, M. Johnson and B. Snyder, Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease, Neurosci Lett 159 (1993), 88-90.
24. G. Torsdottir, J. Kristinsson, S. Hreidarsson, J. Snaedal and T. Johannesson, Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome, Pharmacol Toxicol 89 (2001), 320-325.
25. G.A. Carlson, D.R. Borchelt, A. Dake, S. Turner, V. Danielson, J.D. Coffin, C. Eckman, J. Meiners, S.P. Nilsen, S.G. Younkin and K.K. Hsiao, Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice, Hum Mol Genet 6 (1997), 1951-1959.
26. C. Iadecola, F. Zhang, K. Niwa, C. Eckman, S.K. Turner, E. Fischer, S. Younkin, D.R. Borchelt, K.K. Hsiao and G.A. Carlson, SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein, Nat Neurosci 2 (1999), 157-161.
27. D.M. McLoughlin, C.L. Standen, K.F. Lau, S. Ackerley, T.P. Bartnikas, J.D. Gitlin and C.C. Miller, The neuronal adaptor protein X11alpha interacts with the copper chaperone for SOD1 and regulates SOD1 activity, J Biol Chem 276 (2001), 9303-9307.
28. T.B. Bartnikas and J.D. Gitlin, Mechanisms of biosynthesis of mammalian copper/zinc superoxide dismutase, J Biol Chem 278 (2003), 33602-33608.
29. J. Snaedal, J. Kristinsson, S. Gunnarsdottir, Olafsdottir, M. Baldvinsson and T. Johannesson, Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease. A case-control study, Dement Geriatr Cogn Disord 9 (1998), 239-242.
30. J.R. Turnlund, R.A. Jacob, C.L. Keen, J.J. Strain, D.S. Kelley, J.M. Domek, W.R. Keyes, J.L. Ensunsa, J. Lykkesfeldt and J. Coulter, Long-term high copper intake: effects on indexes of copper status, antioxidant status, and immune function in young men, Am J Clin Nutr 79 (2004), 1037-1044.
31. B. Angeletti, K.J. Waldron, K.B. Freeman, H. Bawagan, I. Hussain, C.C. Miller, K.F. Lau, M.E. Tennant, C. Dennison, N.J. Robinson and C. Dingwall, BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper, J Biol Chem 18 (2005), 18.